1966
DOI: 10.1016/0022-510x(66)90045-1
|View full text |Cite
|
Sign up to set email alerts
|

Some aspects of brain-investigation by means of radio-isotopes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1969
1969
1985
1985

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…The demonstration of glioblastomas and meningiomas by scanning is possible in over 90% of cases, while with metastases it is somewhat lower 15,25 The meningiomas which cannot be demonstrated are those which lie suprasellar, basally, and in the posterior fossa. The demonstration of glioblastomas and meningiomas by scanning is possible in over 90% of cases, while with metastases it is somewhat lower 15,25 The meningiomas which cannot be demonstrated are those which lie suprasellar, basally, and in the posterior fossa.…”
Section: Discussionmentioning
confidence: 99%
“…The demonstration of glioblastomas and meningiomas by scanning is possible in over 90% of cases, while with metastases it is somewhat lower 15,25 The meningiomas which cannot be demonstrated are those which lie suprasellar, basally, and in the posterior fossa. The demonstration of glioblastomas and meningiomas by scanning is possible in over 90% of cases, while with metastases it is somewhat lower 15,25 The meningiomas which cannot be demonstrated are those which lie suprasellar, basally, and in the posterior fossa.…”
Section: Discussionmentioning
confidence: 99%
“…Winkelman and Moore (1941) described a complex case with apparent intracerebral as well as subdural Hodgkin's disease but their illustrations are of leucoencephalopathy, as pointed out by Astrom, Mancall, and Richardson (1958). The uptake by tissues of radioactive isotopes is dependent on factors such as vascularity and permeability, the latter being the more obscure in tumours, with possibly an active cellular component (Planiol, 1966). The gamma emitter Technetium-99m, as used in this case, has a short half-life; its Intracranial Hodgkin's disease shown by radioisotope scan .4 tumour concentration and the ratios of this to those in blood and brain allow well-defined pictures for an acceptable dose of radiation and examination time.…”
Section: Case Reportmentioning
confidence: 99%